Epic Capital Management

Acorn Biolabs, Inc. is a biotechnology company based in Toronto, Canada, founded in 2017. It specializes in providing a take-home service for the cryopreservation of human cells, focusing on young cell preservation to facilitate future regenerative medical treatments. The company employs a non-invasive, follicle-based cell collection method, allowing individuals to collect and preserve their healthy young cells for potential use in gene therapies, stem cell therapeutics, tissue engineering, and organ regeneration. Acorn Biolabs offers its services directly to consumers, with options for at-home and in-clinic cell collection. The company also has established partnerships with a network of clinics and pharmacies across Canada to enhance accessibility to its innovative services.

ThoughtWire is a technology company focused on creating smarter environments through its innovative platform, ThoughtWireOS. This platform integrates data from people, processes, and the physical built environment to enhance the efficiency and safety of hospitals, commercial buildings, and cities. By leveraging digital twin technology, ThoughtWire enables intelligent automation and real-time guidance for both machines and staff, helping predict and resolve issues while promoting energy efficiency. The company's applications are designed to prioritize user experience, catering to clinicians, patients, office workers, and first responders, thereby empowering them with control over their environments. ThoughtWire's solutions unlock the value of data generated from built environments, transforming them into self-optimizing systems that contribute to advanced operational efficiency and sustainability.

Muse, developed by InteraXon, is a neurotechnology company that produces a headband designed to provide real-time feedback on brain activity during meditation. Founded in 2007 and headquartered in Toronto, Ontario, the company specializes in brain-computer interfaces, utilizing research-grade ambulatory electroencephalograms and EEG sensors. Muse’s technology captures brainwaves and translates them into digital signals, which are then processed to deliver insights on mental activity, heart rate, breathing, and body movements. This data enables users to enhance their meditation practices and mindfulness, fostering a deeper connection with their mental and physical states. Through its innovative hardware and software platform, Muse aims to support users in achieving greater mental clarity and well-being.

Cyclica Inc. is a Toronto-based company that specializes in enhancing the drug discovery process through its integrated cloud-based platform augmented by artificial intelligence. Founded in 2010, Cyclica offers technologies such as Ligand Design, which generates novel molecules and evaluates their properties, and Ligand Express, a platform that screens small-molecule drugs against structurally-characterized proteins to assess poly-pharmacological profiles. The company's innovative software leverages biophysics and AI to identify potential ligand-protein interactions, enabling health institutions to prioritize candidate drugs, clarify adverse effects, and explore drug repurposing opportunities. Cyclica has also established a strategic partnership with AUM Biosciences to further its mission of improving drug discovery practices.

Circle Cardiovascular Imaging develops and markets post‑processing software for cardiovascular magnetic resonance and computed tomography imaging. Its product suite includes cmr42 for MR images, ct42 for CT images, cvi42 for integrated MR and CT analysis, and report42 for documentation and reporting. The company supplies product support, training, and education services. Its software assists clinicians in diagnosing and managing conditions such as heart failure, coronary artery disease, myocardial infarction, myocarditis, valvular disease, and pulmonary and carotid disease, and is used in both clinical practice and research. Products are distributed worldwide through a network of partners. Founded in 2007 by Kelly Cherniwchan, the company is headquartered in Calgary, Canada, and incorporates big‑data and deep‑learning techniques to enhance image evaluation.

QoC Health Inc. is a healthcare technology company based in Toronto, Canada, established in 2010. It operates a cloud-based digital platform designed to enhance patient engagement and improve healthcare outcomes. The platform provides a range of solutions, including patient monitoring, integration with existing medical records, and tools for research and clinical trials. QoC Health focuses on various healthcare scenarios, such as monitoring post-discharge recovery, offering patient decision aids, and facilitating communication between patients, healthcare providers, and social support networks. By streamlining complex healthcare processes, QoC Health aims to improve patient satisfaction, reduce readmissions, and lower the overall cost of care.

Perimeter Medical Imaging AI is a medical technology company focused on revolutionizing cancer surgery through the development of ultra-high-resolution, real-time imaging tools. These advanced imaging solutions are designed to address significant unmet medical needs in the surgical field, enhancing the ability to detect and delineate cancerous tissues during procedures. By improving the accuracy of surgical interventions, Perimeter aims to optimize patient outcomes and contribute to more effective cancer treatment strategies.

ChipCare Corporation, established in 2009 and headquartered in Toronto, Canada, specializes in developing and manufacturing point-of-care testing systems for health applications. The company's core product is a handheld cell analyzer system designed to conduct various blood tests from a single drop of sample, including cell counting, protein/enzyme detection, and pathogen identification. ChipCare aims to make advanced blood testing accessible globally by offering an integrated solution comprising a handheld reader and disposable test slides, with primary revenue generated through the sale of these consumables. The company's innovative detection technique enables multiplexed testing, addressing clinical challenges in both resource-rich and limited settings.